Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    23andMe Holding Co. (MEUSW)

    Price:

    1.38 USD

    ( - -0.13 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    MEUSW
    Name
    23andMe Holding Co.
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    Price
    1.380
    Market Cap
    0
    Enterprise value
    49.272M
    Currency
    USD
    Ceo
    Anne Wojcicki
    Full Time Employees
    Ipo Date
    2021-06-17
    City
    Sunnyvale
    Address
    223 N. Mathilda Ave.

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Syneos Health, Inc.

    VALUE SCORE:

    0

    Symbol
    SYNH
    Market Cap
    4.458B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    2nd position

    GRAIL, Inc.

    VALUE SCORE:

    9

    Symbol
    GRAL
    Market Cap
    3.317B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    The best

    Medpace Holdings, Inc.

    VALUE SCORE:

    9

    Symbol
    MEDP
    Market Cap
    15.794B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.071
    P/S
    0.088
    P/B
    0.511
    Debt/Equity
    0.831
    EV/FCF
    -0.016
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0.015
    Earnings yield
    -14.120
    Debt/assets
    0.188
    FUNDAMENTALS
    Net debt/ebidta
    0.088
    Interest coverage
    0
    Research And Developement To Revenue
    0.556
    Intangile to total assets
    0.162
    Capex to operating cash flow
    -0.036
    Capex to revenue
    0.032
    Capex to depreciation
    0.283
    Return on tangible assets
    -1.945
    Debt to market cap
    1.770
    Piotroski Score
    FUNDAMENTALS
    PEG
    -0.004
    P/CF
    -0.107
    P/FCF
    -0.095
    RoA %
    -163.040
    RoIC %
    -310.865
    Gross Profit Margin %
    53.330
    Quick Ratio
    0.687
    Current Ratio
    0.808
    Net Profit Margin %
    -134.541
    Net-Net
    -2.338
    FUNDAMENTALS PER SHARE
    FCF per share
    -5.854
    Revenue per share
    6.363
    Net income per share
    -8.561
    Operating cash flow per share
    -5.650
    Free cash flow per share
    -5.854
    Cash per share
    1.449
    Book value per share
    1.186
    Tangible book value per share
    0.336
    Shareholders equity per share
    1.186
    Interest debt per share
    0.986
    TECHNICAL
    52 weeks high
    5.720
    52 weeks low
    1.150
    Current trading session High
    1.740
    Current trading session Low
    1.330
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    DESCRIPTION

    23andMe, Inc., a consumer genetics and research company, engages in developing a genetic database to unlock insights leading to the rapid discovery of new targets for drug development. It offers a crowdsourced platform that helps people to access, understand, and benefit from the human genome; access direct-to-consumer genetic testing; and give consumers personalized information about their genetic health risks, ancestry, and traits. The company was incorporated in 2006 and is based in Sunnyvale, California with an additional office in Mountain View, California.

    NEWS